UK approval for AbbVie Crohn’s disease drug
AbbVie has announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved…
February 3, 2023 - 3 minutes
United Kingdom
Advancing cancer care with 3D genomics
By Oxford BioDynamics Cancer care is in urgent need of effective tests to determine the…
February 1, 2023 - 7 minutes
BiVictriX announces positive data from leukemia study
BiVictriX Therapeutics plc has announced positive in vivo data from a toxicity evaluation study with…
January 31, 2023 - 3 minutes
Ubiquigent and University of Glasgow to collaborate on drug discovery
Ubiquigent Limited, a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new…
January 24, 2023 - 3 minutes
Funding for university to develop new motor neuron disease therapies
Medical research charity LifeArc, the Motor Neurone Disease Association (MND Association) and the My Name’5…
January 24, 2023 - 4 minutes
Watch: Queen’s University tackling antimicrobial resistance
One of the biggest global challenges facing healthcare systems is bacteria and viruses becoming resistant…
January 24, 2023 - 2 minutes
Watch: pHion Therapeutics talks about next-generation mRNA vaccines
pHion Therapeutics is a U.K.-based vaccine development company. It is developing a pipeline of therapeutic…
January 23, 2023 - 1 minute
Cloned maggot enzyme wound treatment moves closer to reality
Cambridge U.K. biotech company SolasCure, which is developing a wound cleaning technology, has published its…
January 19, 2023 - 2 minutes
Multus Biotechnology closes $9.5M funding to bring cultivated meat closer to price parity
Multus Biotechnology Limited, a U.K.-based start-up creating ingredients for the affordable scale-up of cellular agriculture,…
January 17, 2023 - 2 minutes
TTP spinout Cellular Origins to focus on cell and gene therapies
TTP plc, a technology and product development company, has announced the launch of Cellular Origins. …
January 17, 2023 - 3 minutes
Collaboration to boost pandemic preparedness, structure-based drug discovery and vaccine design
A new Memorandum of Understanding (MoU) to facilitate collaboration in the field of pandemic preparedness…
January 12, 2023 - 3 minutes
BioNTech partnering with UK Government on personalized mRNA cancer immunotherapies
BioNTech SE has signed a memorandum of understanding (MoU) with the Government of the United…
January 6, 2023 - 4 minutes
